Planned FCFS (NASDAQ: FCFS) stock sale and recent 10b5-1 trades

Rhea-AI Filing Summary

A holder of FCFS common stock filed a notice to sell 1,000 shares through Morgan Stanley Smith Barney on 02/17/2026 on Nasdaq, with an aggregate market value of $181,890. Shares outstanding were 43,984,696, which is a baseline figure, not the amount being sold.

The filing also lists recent Rule 10b5-1 plan sales over the past three months: 4,000 common shares for $701,489.60 by ROBERT DOUGLAS ORR JR. IRRV TRUST, 1,500 shares for $262,444.95 by JAYNE M ORR IRREVOCABLE TRUST, and 2,000 shares for $350,029.40 by YELLOW LAB PROPERTIES, LP.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1000	181890.00	43984696	02/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/27/2015	Previously Exercised Stock Options	Issuer			1000	10/27/2015	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ROBERT DOUGLAS ORR JR. IRRV TRUST 1600 West 7th Street Fort Worth TX 76102	Common	02/05/2026	4000	701489.60
10b5-1 Sales for JAYNE M ORR IRREVOCABLE TRUST 1600 West 7th Street Fort Worth TX 76102	Common	02/05/2026	1500	262444.95
10b5-1 Sales for YELLOW LAB PROPERTIES, LP 1600 West 7th Street Fort Worth TX 76102	Common	02/05/2026	2000	350029.40

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the latest Form 144 filing reveal for FCFS?

The Form 144 for FCFS shows an intent to sell 1,000 common shares on Nasdaq, with an aggregate market value of $181,890. The shares will be sold through Morgan Stanley Smith Barney under Rule 144.

How many FCFS shares are planned to be sold under this Form 144?

The filing indicates a planned sale of 1,000 FCFS common shares. These shares have an aggregate market value of $181,890 and will be sold on Nasdaq through Morgan Stanley Smith Barney under Rule 144 procedures.

What recent Rule 10b5-1 plan sales related to FCFS are disclosed?

The notice lists recent 10b5-1 sales of FCFS stock: 4,000 shares for $701,489.60, 1,500 shares for $262,444.95, and 2,000 shares for $350,029.40 by three separate trusts and a limited partnership.

Who are the entities selling FCFS shares in the past three months?

The entities selling FCFS shares under Rule 10b5-1 plans are ROBERT DOUGLAS ORR JR. IRRV TRUST, JAYNE M ORR IRREVOCABLE TRUST, and YELLOW LAB PROPERTIES, LP, each reporting common stock sales and related gross proceeds.

How many FCFS shares are outstanding according to the notice?

The Form 144 disclosure shows 43,984,696 FCFS common shares outstanding. This figure serves as a baseline share count and is separate from the 1,000-share planned sale described in the same filing.

What is the source of the 1,000 FCFS shares being sold?

The 1,000 FCFS common shares were acquired on 10/27/2015 through previously exercised stock options from the issuer, paid in cash on the same date, according to the acquisition details in the notice.